Zanosar (streptozocin) / Teva  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zanosar (streptozocin) / Teva
NCT00004688: Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

Completed
2
35
US
carmustine, mercaptopurine, streptozocin
Emory University
Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Mixed Gliomas, Glioblastoma Multiforme, Recurrent Brain Tumor
 
07/98
NCT00609765: Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors

Terminated
2
1
US
Avastin, bevacizumab, Fluorouracil, Fluoroplex, 5-FU, Efudex, Doxorubicin, Adriamycin®, Streptozocin, Zanosar®, Dexamethasone, Decadron, Ondansetron, Zofran
H. Lee Moffitt Cancer Center and Research Institute, Genentech, Inc.
Pancreatic Cancer
03/08
03/08
NCT00602082: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Completed
2
84
Europe
capecitabine, cisplatin, streptozocin, DNA analysis, RNA analysis, protein analysis, proteomic profiling, laboratory biomarker analysis
Cambridge University Hospitals NHS Foundation Trust
Gastrointestinal Carcinoid Tumor, Islet Cell Tumor
12/09
12/09
NCT02788201: Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma

Completed
2
8
US
75 approved agents, COXEN
National Cancer Institute (NCI)
Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms
10/19
10/19
BETTER 2, NCT03351296: Two Chemotherapy Regimens Plus or Minus Bevacizumab

Active, not recruiting
2
140
Europe
LV5FU2, Streptozocin, Capecitabine, Temozolomide, Bevacizumab
Gustave Roussy, Cancer Campus, Grand Paris, National Cancer Institute, France
Pancreatic Cancer
12/28
12/28

Download Options